BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

737 related articles for article (PubMed ID: 28627984)

  • 1. Diagnostic accuracy of proton magnetic resonance spectroscopy and perfusion-weighted imaging in brain gliomas follow-up: a single institutional experience.
    Anselmi M; Catalucci A; Felli V; Vellucci V; Di Sibio A; Gravina GL; Di Staso M; Di Cesare E; Masciocchi C
    Neuroradiol J; 2017 Jun; 30(3):240-252. PubMed ID: 28627984
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Diagnostic Value of Apparent Diffusion Coefficient and Proton Magnetic Resonance Spectroscopy in the Grading of Pediatric Gliomas.
    Yao R; Cheng A; Liu M; Zhang Z; Jin B; Yu H
    J Comput Assist Tomogr; 2021 Mar-Apr 01; 45(2):269-276. PubMed ID: 33346568
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Grading diffuse gliomas without intense contrast enhancement by amide proton transfer MR imaging: comparisons with diffusion- and perfusion-weighted imaging.
    Togao O; Hiwatashi A; Yamashita K; Kikuchi K; Keupp J; Yoshimoto K; Kuga D; Yoneyama M; Suzuki SO; Iwaki T; Takahashi M; Iihara K; Honda H
    Eur Radiol; 2017 Feb; 27(2):578-588. PubMed ID: 27003139
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of three different MR perfusion techniques and MR spectroscopy for multiparametric assessment in distinguishing recurrent high-grade gliomas from stable disease.
    Seeger A; Braun C; Skardelly M; Paulsen F; Schittenhelm J; Ernemann U; Bisdas S
    Acad Radiol; 2013 Dec; 20(12):1557-65. PubMed ID: 24200483
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The diagnostic performance of magnetic resonance spectroscopy in differentiating high-from low-grade gliomas: A systematic review and meta-analysis.
    Wang Q; Zhang H; Zhang J; Wu C; Zhu W; Li F; Chen X; Xu B
    Eur Radiol; 2016 Aug; 26(8):2670-84. PubMed ID: 26471274
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Usefulness of quantitative peritumoural perfusion and proton spectroscopic magnetic resonance imaging evaluation in differentiating brain gliomas from solitary brain metastases.
    Sparacia G; Gadde JA; Iaia A; Sparacia B; Midiri M
    Neuroradiol J; 2016 Jun; 29(3):160-7. PubMed ID: 26988081
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Magnetic resonance perfusion for differentiating low-grade from high-grade gliomas at first presentation.
    Abrigo JM; Fountain DM; Provenzale JM; Law EK; Kwong JS; Hart MG; Tam WWS
    Cochrane Database Syst Rev; 2018 Jan; 1(1):CD011551. PubMed ID: 29357120
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glioma grading prediction using multiparametric magnetic resonance imaging-based radiomics combined with proton magnetic resonance spectroscopy and diffusion tensor imaging.
    Lin K; Cidan W; Qi Y; Wang X
    Med Phys; 2022 Jul; 49(7):4419-4429. PubMed ID: 35366379
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intergrating conventional MRI, texture analysis of dynamic contrast-enhanced MRI, and susceptibility weighted imaging for glioma grading.
    Su CQ; Lu SS; Han QY; Zhou MD; Hong XN
    Acta Radiol; 2019 Jun; 60(6):777-787. PubMed ID: 30244590
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The utility of magnetic resonance spectroscopy in frame-less stereotactic needle biopsy of glioma.
    Wang Q; Zhang J; Li F; Chen X; Xu B
    J Clin Neurosci; 2021 Jun; 88():102-107. PubMed ID: 33992167
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Measurements of diagnostic examination performance using quantitative apparent diffusion coefficient and proton MR spectroscopic imaging in the preoperative evaluation of tumor grade in cerebral gliomas.
    Server A; Kulle B; Gadmar ØB; Josefsen R; Kumar T; Nakstad PH
    Eur J Radiol; 2011 Nov; 80(2):462-70. PubMed ID: 20708868
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Grading of Glioma: combined diagnostic value of amide proton transfer weighted, arterial spin labeling and diffusion weighted magnetic resonance imaging.
    Kang XW; Xi YB; Liu TT; Wang N; Zhu YQ; Wang XR; Guo F
    BMC Med Imaging; 2020 May; 20(1):50. PubMed ID: 32408867
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment monitoring in gliomas: comparison of dynamic susceptibility-weighted contrast-enhanced and spectroscopic MRI techniques for identifying treatment failure.
    Vöglein J; Tüttenberg J; Weimer M; Gerigk L; Kauczor HU; Essig M; Weber MA
    Invest Radiol; 2011 Jun; 46(6):390-400. PubMed ID: 21285888
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differentiation between intra-axial metastatic tumor progression and radiation injury following fractionated radiation therapy or stereotactic radiosurgery using MR spectroscopy, perfusion MR imaging or volume progression modeling.
    Huang J; Wang AM; Shetty A; Maitz AH; Yan D; Doyle D; Richey K; Park S; Pieper DR; Chen PY; Grills IS
    Magn Reson Imaging; 2011 Sep; 29(7):993-1001. PubMed ID: 21571478
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glioma grading using multiparametric MRI: head-to-head comparison among dynamic susceptibility contrast, dynamic contrast-enhancement, diffusion-weighted images, and MR spectroscopy.
    Seo M; Choi Y; Soo Lee Y; Ahn KJ; Kim BS; Park JS; Jeon SS
    Eur J Radiol; 2023 Aug; 165():110888. PubMed ID: 37257338
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolic approach for tumor delineation in glioma surgery: 3D MR spectroscopy image-guided resection.
    Zhang J; Zhuang DX; Yao CJ; Lin CP; Wang TL; Qin ZY; Wu JS
    J Neurosurg; 2016 Jun; 124(6):1585-93. PubMed ID: 26636387
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of unsupervised classification methods for brain tumor segmentation using multi-parametric MRI.
    Sauwen N; Acou M; Van Cauter S; Sima DM; Veraart J; Maes F; Himmelreich U; Achten E; Van Huffel S
    Neuroimage Clin; 2016; 12():753-764. PubMed ID: 27812502
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multimodal MRI in the characterization of glial neoplasms: the combined role of single-voxel MR spectroscopy, diffusion imaging and echo-planar perfusion imaging.
    Zonari P; Baraldi P; Crisi G
    Neuroradiology; 2007 Oct; 49(10):795-803. PubMed ID: 17619871
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pre- and Posttreatment Glioma: Comparison of Amide Proton Transfer Imaging with MR Spectroscopy for Biomarkers of Tumor Proliferation.
    Park JE; Kim HS; Park KJ; Kim SJ; Kim JH; Smith SA
    Radiology; 2016 Feb; 278(2):514-23. PubMed ID: 26491847
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biopsy targeting gliomas: do functional imaging techniques identify similar target areas?
    Weber MA; Henze M; Tüttenberg J; Stieltjes B; Meissner M; Zimmer F; Burkholder I; Kroll A; Combs SE; Vogt-Schaden M; Giesel FL; Zoubaa S; Haberkorn U; Kauczor HU; Essig M
    Invest Radiol; 2010 Dec; 45(12):755-68. PubMed ID: 20829706
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 37.